BioSpace News Archive

Business

Optibrium Expands U.S. and U.K. Operations

Optibrium today announced it has appointed Dr. Scott Lyon as Director of Business Development and relocated its Headquarters and R&D facilities, to Cambridge Innovation Park, Cambridge, UK.

January 30, 2018
·
2 min read
Medtronic Shows Off IN.PACT Global Critical Limb Ischemia Study Data

The new data was presented at the Leipzig Interventional Course (LINC) in Leipzig, Germany.

January 30, 2018
·
5 min read
Drug Development

Cumberland Pharma Release: Newly Published Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity for Multiple Myeloma Patients

The study, led by Ehsan Malek, MD at Case Western Reserve University, assessed multiple myeloma patients receiving high dose melphalan followed by auto-HTC.

January 30, 2018
·
5 min read
Business

FDA, USDA Announce Formal Agreement to Bolster Coordination and Collaboration

The formal agreement outlines efforts to increase interagency collaboration, efficiency and effectiveness on produce safety and biotechnology activities, while providing clarity to manufacturers.

January 30, 2018
·
5 min read
Business

BioInvent Financial Statement 1 January - 31 December 2017

BioInvent to co-develop dual mechanism anti-cancer drug with Transgene.

January 30, 2018
·
4 min read
Biotech Bay

Marrone Bio Innovations’ Haven Sun Protectant Approved in California

In addition, trials in California over the last two years show that Haven applications resulted in significantly higher almond and walnut yields, compared to competing products.

January 30, 2018
·
6 min read
Policy

Momenta Pharmaceuticals Announces Positive Outcome for Contracted Glatopa (Glatiramer Acetate Injection) Fill/Finish Manufacturer

The FDA has classified the outcome of its fourth quarter 2017 reinspection of Pfizer’s McPherson facility as Voluntary Action Indicated.

January 30, 2018
·
3 min read
Planmeca Emerald Intraoral Scanner Now Accepted by the WIN System

WIN lingual braces work in the same way as conventional fixed braces, with full control and movement of the teeth, but they are invisible from the outside.

January 30, 2018
·
2 min read
Business

Michael J. Fox Foundation Partnering on Program to Expand Molecular Investigation of Parkinson’s Disease

This project grows work ongoing in the MJFF-led PPMI and builds on the NIH Accelerating Medicines Partnership model.

January 30, 2018
·
4 min read
Drug Development

FDA Grants Orphan Drug Designation to Dauntless Pharma’s DP1038 for the Treatment of Acromegaly

The FDA grants orphan drug status to promote the development of novel products to treat conditions affecting fewer than 200,000 people in the United States.

January 30, 2018
·
2 min read